Literature DB >> 9843461

Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes.

V A Maltsev1, H N Sabbah, R S Higgins, N Silverman, M Lesch, A I Undrovinas.   

Abstract

BACKGROUND: Alterations in K+ channel expression and gating are thought to be the major cause of action potential remodeling in heart failure (HF). We previously reported the existence of a late Na+ current (INaL) in cardiomyocytes of dogs with chronic HF, which suggested the importance of the Na+ channel in this remodeling process. The present study examined whether this INaL exists in cardiomyocytes isolated from normal and failing human hearts. METHODS AND
RESULTS: A whole-cell patch-clamp technique was used to measure ion currents in cardiomyocytes isolated from the left ventricle of explanted hearts from 10 patients with end-stage HF and from 3 normal hearts. We found INaL was activated at a membrane potential of -60 mV with maximum density (0.34+/-0.05 pA/pF) at -30 mV in cardiomyocytes of both normal and failing hearts. The steady-state availability was sigmoidal, with an averaged midpoint potential of -94+/-2 mV and a slope factor of 6.9+/-0.1 mV. The current was reversibly blocked by the Na+ channel blockers tetrodotoxin (IC50=1.5 micromol/L) and saxitoxin (IC50=98 nmol/L) in a dose-dependent manner. Both inactivation and reactivation of INaL had an ultraslow time course (tau approximately 0.6 seconds) and were independent of voltage. The amplitude of INaL was independent of the peak transient Na+ current.
CONCLUSIONS: Cardiomyocytes isolated from normal and explanted failing human hearts express INaL characterized by an ultraslow voltage-independent inactivation and reactivation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843461     DOI: 10.1161/01.cir.98.23.2545

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  117 in total

1.  Engineered calmodulins reveal the unexpected eminence of Ca2+ channel inactivation in controlling heart excitation.

Authors:  Badr A Alseikhan; Carla D DeMaria; Henry M Colecraft; David T Yue
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

Review 2.  Sudden death in heart failure: underlying electrophysiological mechanisms.

Authors:  Subramaniam C Krishnan; Claudio D Schuger; Sidney Goldstein
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

3.  Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure.

Authors:  Stephen Zicha; Victor A Maltsev; Stanley Nattel; Hani N Sabbah; Albertas I Undrovinas
Journal:  J Mol Cell Cardiol       Date:  2004-07       Impact factor: 5.000

4.  A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes.

Authors:  Victor A Maltsev; Albertas I Undrovinas
Journal:  Cardiovasc Res       Date:  2005-10-11       Impact factor: 10.787

Review 5.  Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload.

Authors:  D Noble; P J Noble
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

Review 6.  Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.

Authors:  Charles Antzelevitch
Journal:  Europace       Date:  2007-09       Impact factor: 5.214

Review 7.  Autonomic aspects of arrhythmogenesis: the enduring and the new.

Authors:  Richard L Verrier; Charles Antzelevitch
Journal:  Curr Opin Cardiol       Date:  2004-01       Impact factor: 2.161

8.  Overexpression of the Na+/K+ ATPase α2 but not α1 isoform attenuates pathological cardiac hypertrophy and remodeling.

Authors:  Robert N Correll; Petra Eder; Adam R Burr; Sanda Despa; Jennifer Davis; Donald M Bers; Jeffery D Molkentin
Journal:  Circ Res       Date:  2013-11-11       Impact factor: 17.367

Review 9.  Cardiac repolarization. The long and short of it.

Authors:  Charles Antzelevitch
Journal:  Europace       Date:  2005-09       Impact factor: 5.214

Review 10.  Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart.

Authors:  Albertas Undrovinas; Victor A Maltsev
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.